Még nem toboroz
Biomarker-guided RAdiation-deferring Treatment in Younger GBM Patients - Pilot Study
NCT07908147· Korai 1. fázis· Olivia Newton-John Cancer Research Institute· Forrás
Contact: Hui Prof. Gan
Még nem toboroz
Radiotherapy in Combination With Glofitamab in Relapsed/Refractory Diffuse Large B Cell Lymphoma
NCT07634289· 2. fázis· Olivia Newton-John Cancer Research Institute· Forrás
Contact: Prof. Eliza Hawkes
Toboroz
Feasibility Study of the iVEAcare Neuromodulation System for the Treatment of Drug-Resistant Epilepsy
NCT07640191· iVEAcare· Forrás
Contact: Greesha Zacharia
Toboroz
Safety, Tolerability, and Pharmacokinetics of SVG103 (Paxalisib) in Focal Cortical Dysplasia Type II (FCD-II), Tuberous Sclerosis Complex (TSC) or Hemimegalencephaly (HME)
NCT07287202· 1/2. fázis· Sovargen· Forrás
Contact: Epilepsy Research Centre
Toboroz
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
NCT07518186· 3. fázis· Janssen Research & Development, LLC· Forrás
Toboroz
A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Activity of GDC-1261 in Participants With Advanced or Metastatic Prostate Cancer
NCT07567846· 1/2. fázis· Genentech, Inc.· Forrás
Toboroz
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
NCT07284849· 3. fázis· Incyte Corporation· Forrás
Toboroz
A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy With Standard-of-Care Combination Regimens in Adult Participants With Relapsed/Refractory Multiple Myeloma (RRMM)
NCT07222761· 3. fázis· Regeneron Pharmaceuticals· Forrás
Contact: Clinical Trials Administrator
Toboroz
A Study to Learn How Safe and How Well Linvoseltamab Works Compared to Standard Treatment in Adult Patients With Multiple Myeloma Who Are Not Eligible for Transplant
NCT06932562· 3. fázis· European Myeloma Network B.V.· Forrás
Contact: Hocking
Toboroz
A Study to Evaluate Efficacy and Safety of Ciltacabtagene Autoleucel
NCT07149857· 2. fázis· Janssen Research & Development, LLC· Forrás
Meghívásos bevonás
A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathy (DEE)
NCT06908226· 3. fázis· Longboard Pharmaceuticals· Forrás
Fut, nem toboroz
A Study of Tagraxofusp in Combination With Venetoclax and Azacitidine in Adults With Untreated CD123+ Acute Myeloid Leukemia Who Cannot Undergo Intensive Chemotherapy
NCT06456463· 2. fázis· Stemline Therapeutics, Inc.· Forrás
Toboroz
Study of IBI3009 in Participants with Unresectable, Metastatic or Extensive-Stage Small Cell Lung Cancer
NCT06613009· 1. fázis· Innovent Biologics (Suzhou) Co. Ltd.· Forrás
Contact: Lue Shen
Fut, nem toboroz
A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis.
NCT06588686· 2. fázis· Vicore Pharma AB· Forrás
Fut, nem toboroz
A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathies (DEE)
NCT06719141· 3. fázis· Longboard Pharmaceuticals· Forrás
Toboroz
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
NCT06561048· 3. fázis· Corvus Pharmaceuticals, Inc.· Forrás
Contact: Samantha Chakar
Fut, nem toboroz
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast
NCT06238622· 3. fázis· Boehringer Ingelheim· Forrás
Fut, nem toboroz
A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)
NCT06660394· 3. fázis· Longboard Pharmaceuticals· Forrás
Fut, nem toboroz
A Study of Ciltacabtagene Autoleucel and Talquetamab for the Treatment of Participants With High-Risk Multiple Myeloma
NCT06550895· 2. fázis· Janssen Research & Development, LLC· Forrás
Fut, nem toboroz
Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN)
NCT06564142· 3. fázis· Alpine Immune Sciences Inc, A Subsidiary of Vertex· Forrás
Toboroz
IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)
NCT06112314· 3. fázis· Immunocore Ltd· Forrás
Toboroz
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
NCT05485961· 2/3. fázis· CSL Behring· Forrás
Contact: Trial Registration Coordinator
Fut, nem toboroz
Magnetic Sentinel Lymph Node Mapping in Upper Gastro-Intestinal Cancer: A Feasibility Clinical Investigation
NCT05899985· Ferronova Pty Ltd· Forrás
Fut, nem toboroz
T Cells and Pembrolizumab for Recurrent and Newly Diagnosed Glioblastoma
NCT06157541· 1/2. fázis· Queensland Institute of Medical Research· Forrás
Toboroz
Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate)
NCT05658497· Biogen· Forrás
Contact: US Biogen Clinical Trial Center
Toboroz
A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma
NCT05730036· 3. fázis· Regeneron Pharmaceuticals· Forrás
Contact: Clinical Trials Administrator
Toboroz
A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer
NCT05800665· 1. fázis· Genentech, Inc.· Forrás
Toboroz
Alleviant ALLAY-HF Study
NCT05685303· Alleviant Medical, Inc.· Forrás
Contact: Matias Yudi (principal investigator)
Fut, nem toboroz
Bringing Optimised COVID-19 Vaccine Schedules To ImmunoCompromised Populations (BOOST-IC): an Adaptive Randomised Controlled Clinical Trial
NCT05556720· 3. fázis· Monash University· Forrás
Toboroz
Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Immunoglobulin Stopping or Extension
NCT05678621· 2/3. fázis· Monash University· Forrás
Contact: Prof Zoe McQuilten
Toboroz
Pembrolizumab and Brentuximab Vedotin vs GDP and Stem Cell Transplant for Relapsed/Refractory Hodgkin Lymphoma
NCT05180097· 2. fázis· Canadian Cancer Trials Group· Forrás
Contact: Eliza Hawkes
Toboroz
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
NCT05254171· 2/3. fázis· Panbela Therapeutics, Inc.· Forrás
Contact: Niall Tebbutt
Fut, nem toboroz
Study of Dato-DXd Plus Pembrolizumab vs Pembrolizumab Alone in the First-line Treatment of Subjects With Advanced or Metastatic NSCLC Without Actionable Genomic Alterations
NCT05215340· 3. fázis· Daiichi Sankyo· Forrás
Toboroz
HCC Surveillance: Comparison of Abbreviated Non-contrast MRI and Ultrasound Surveillance in Cirrhotic Patients With Suboptimal Ultrasound Visualisation
NCT04455932· Concord Repatriation General Hospital· Forrás
Contact: Numan Kutaiba
Fut, nem toboroz
A Study to Test BI 765179 Alone and in Combination With Ezabenlimab in Patients With Advanced Cancer (Solid Tumors) and BI 765179 in Combination With Pembrolizumab in Patients With Advanced Head and Neck Cancer
NCT04958239· 1. fázis· Boehringer Ingelheim· Forrás
Toboroz
Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs
NCT04613921· European Foundation for Study of Chronic Liver Failure· Forrás
Contact: Marie Sinclair
Fut, nem toboroz
Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)
NCT04822181· 3. fázis· Novo Nordisk A/S· Forrás
Fut, nem toboroz
Study of DS-1062a Versus Docetaxel in Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer With or Without Actionable Genomic Alterations (TROPION-LUNG01)
NCT04656652· 3. fázis· Daiichi Sankyo· Forrás
Fut, nem toboroz
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS)
NCT04544436· 3. fázis· Hoffmann-La Roche· Forrás
Fut, nem toboroz
A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis
NCT04544449· 3. fázis· Hoffmann-La Roche· Forrás
Fut, nem toboroz
A Study of Amivantamab and Lazertinib Combination Therapy Versus Osimertinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer
NCT04487080· 3. fázis· Janssen Research & Development, LLC· Forrás
Toboroz
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
NCT04429542· 1. fázis· Bicara Therapeutics· Forrás
Contact: Alesha Thai, MBBS, FRACP, PhD (principal investigator)
Fut, nem toboroz
A Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
NCT04035005· 3. fázis· Hoffmann-La Roche· Forrás
Fut, nem toboroz
Assessing an Oral EGFR Inhibitor, Sunvozertinib in Patients Who Have Advanced Non-small Cell Lung Cancer With EGFR or HER2 Mutation (WU-KONG1)
NCT03974022· 1/2. fázis· Dizal Pharmaceuticals· Forrás
Fut, nem toboroz
A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
NCT03466411· 2/3. fázis· Janssen Research & Development, LLC· Forrás
Fut, nem toboroz
Nivolumab and Temozolomide Versus Temozolomide Alone in Newly Diagnosed Elderly Patients With GBM
NCT04195139· 2. fázis· University of Sydney· Forrás
Fut, nem toboroz
Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer
NCT02446405· 3. fázis· University of Sydney· Forrás